Is the business good?
How good a business is ATAI?
AtaiBeckley Inc. keeps −15751% of every revenue dollar as operating profit, against −72% for the median Biotechnology name.
−15751%
Operating margin · Biotechnology median −72% · fiscal year to FY2025
- Share count, year on year
- +41%
Share count, year on year · shareholders own a smaller slice than a year ago
- R&D as % of revenue
- 1298%
R&D as % of revenue
Details›
- Operating marginfiscal year to FY2025
- −15751%
- Net marginfiscal year to FY2025
- −16142%
- Free cash flow margin
- −2533%
- R&D as % of revenue
- 1298%
- Revenue, trailing twelve months
- $4.1M
- Free cash flow, trailing twelve months
- −$104M
- Net income, trailing twelve months
- −$660M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.